On September 28, 2026, Calgary-based Flora Fertility (FLORA), which calls itself the first individually owned fertility insurance platform, announced a partnership with period and cycle tracker Clue. The deal works in both directions. Clue will introduce FLORA's proactive fertility insurance to its users. New and existing FLORA policyholders get free access to Clue Plus, Clue's premium subscription with advanced cycle insights, predictions and pattern analysis, alongside up to $50,000 in future fertility coverage through FLORA.

Why It Matters

This is a distribution deal, and in femtech distribution is the scarce asset. Cycle trackers own the largest top-of-funnel audience of women thinking about their reproductive health, but they have struggled to monetise it beyond subscriptions without crossing privacy lines. Afterglow has tracked Flo's privacy fights and Clue's own move into insurer-covered tracking. A co-marketing arrangement in which Clue introduces a regulated financial product, and the insurer pays for Clue's premium tier, monetises the audience without selling cycle data, at least as announced. How the referral works in practice, and what data (if any) moves between the two apps, is the detail to watch. For FLORA, the logic is actuarial as much as marketing. Individually owned fertility insurance only pencils out if you enrol people young, well before they need IVF, and a period-tracking audience in its twenties is exactly that pool. The broader signal fits a pattern Afterglow flagged in PwC's $45B fertility market forecast: the money is moving upstream, from treatment toward prediction, planning and financing. Expect more pairings between tracking apps and financial or clinical products as femtech companies look for revenue that doesn't depend on selling users' reproductive data.

According to FLORA and Femtech Insider, the policies start at $15 a month and cover diagnostics, medications, IUI and IVF for women aged 20 to 34. They are backed by A-rated insurance partners and a global reinsurance panel. The pitch is timing. Most fertility education and financial support reaches people only after they start trying or run into a problem, while FLORA cites figures that 69% of Gen Z women worry about their future fertility and 59% feel uninformed about their reproductive health. "Clue provides the insights to understand their reproductive health, while FLORA gives them a way to prepare financially for fertility care they may need later," said Dr. Christy Lane, FLORA's co-founder and co-CEO. Co-founder and co-CEO Laura McDonald added that "most women are taught how to prevent pregnancy, but very little about how fertility changes over time." Clue commercial director Hugo Marshall framed it as bringing "fertility education into that conversation earlier." Clue says it is trusted by more than 100 million people worldwide and is available in over 27 languages.

Financial terms were not disclosed.

Sources

Update — 2026-09-29

Initial entry — story first created.